Life sciences company Aptamer issued a note this morning advising that the company had secured a five year contract extension with a top 5 global pharma partner. Perhaps the most critical point here is that Aptamer retains the ownership of the IP associated with the project, positioning the company to further commercialise this project in the future. Management have declared the deal as being a milestone event. The Aptamer share price was up almost 7% in early trade.
The exploration and resource development company issued a note this morning containing assay results from its latest drilling campaign in Western Australia. Management noted that the numbers confirm the exceptional scale and grade of titanium mineralisation, especially at shallow depths. This paves the way for the company to calculate JORC-compliant Mineral Resource Estimates which will be closely followed. The Empire Metals share price was up 16% shortly after the open.
The oil and gas development company Pantheon provided a market update this morning noting that pilot appraisals of a project on the Alaskan North Slope had exceeded pre-drill estimates whilst also confirming the presence of additional prospective resources in its secondary objectives. The company is now moving towards planning capital efficient commercial production. The Pantheon share price was 13% higher at 8.30am.
Most read news on Investegate this morning
Dubhe-1 Appraisal Well Exceeds Pre-Drill Estimates - - Pantheon Resources (PANR)
Breccia Pipe Intersected at Red Setter Project - - Wishbone Gold (DI) (WSBN)
Drilling Outlines Large, High-Grade Zone - - Empire Metals Limited NPV (DI) (EEE)
